EP Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$948K Buy
11,993
+3,600
+43% +$306K ﹤0.01% 769
2026
Q1
$723K Buy
8,393
+1,443
+21% +$130K ﹤0.01% 752
2025
Q4
$607K Buy
+6,950
New +$528K ﹤0.01% 789
2025
Q2
$200K Buy
+3,394
New +$219K ﹤0.01% 1259

Other funds holding GMED

EP Wealth Advisors's GMED Position: Q2 2026 in Review

EP Wealth Advisors increased its Globus Medical (GMED) stake by 43% in Q2 2026, buying an estimated $306K and bringing the position to 11,993 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #769.

EP Wealth Advisors first reported a position in GMED in Q2 2025 and has held it in 4 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • EP Wealth Advisors held 11,993 shares of Globus Medical worth $948K as of Q2 2026.
  • EP Wealth Advisors bought 3,600 Globus Medical shares in Q2 2026, an estimated $306K.
  • Globus Medical made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #769 holding.
  • EP Wealth Advisors first reported a position in Globus Medical in Q2 2025 and has held it in 4 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.